1112
K. Aikawa et al. / Tetrahedron: Asymmetry 25 (2014) 1104–1115
4.5.4. (R)-Ethyl 2-(5-(((tert-butyldiphenylsilyl)oxy)methyl)-
furan-2-yl)-2-hydroxyacetate 6d
[M+Na]+: 223.0405, found: 223.0394; [
a]
25 = ꢀ59.7 (c 1.16, CHCl3),
D
99% ee; HPLC (column, CHIRALPAK AD-3, Hexane/2-Propa-
nol = 97:3, flow rate 0.6 mL/min, 20 °C, detection UV 210 nm) tR
of minor isomer 35.2 min, tR of major isomer 39.6 min. The abso-
lute configuration was tentatively assigned by analogy of the spe-
cific rotation.
1H NMR (300 MHz, CDCl3) d 1.05 (s, 9H), 1.26 (t, J = 7.2 Hz, 3H),
3.30 (br s, 1H), 4.21–4.33 (m, 2H), 4.62 (s, 1H), 5.14 (s, 2H), 6.12 (d,
J = 3.3 Hz, 1H), 6.29 (d, J = 3.3 Hz, 1H), 7.38–7.70 (m, 10H); 13C NMR
(75 MHz, CDCl3) d 14.1, 19.2, 26.7, 58.9, 62.5, 67.0, 108.2, 109.3,
127.6, 129.7, 133.2, 135.6, 150.3, 154.6, 171.5; FT-IR (KBr pellet,
cmꢀ1) 3488, 2959, 2931, 2857, 1739, 1428, 1219, 1110, 1073,
1015, 823, 701, 610; HRMS (ESI-TOF) calcd for C25H30NaO5Si
4.5.9. (R)-Ethyl 2-hydroxy-2-(5-phenylthiophen-2-yl)acetate 6i
1H NMR (300 MHz, CDCl3) d 1.33 (t, J = 7.2 Hz, 3H), 3.58 (d,
J = 6.0 Hz, 1H), 4.30–4.35 (m, 2H), 5.41 (d, J = 4.8 Hz, 1H), 7.08 (d,
J = 3.9 Hz, 1H), 7.20 (d, J = 3.6 Hz, 1H), 7.28–7.42 (m, 3H), 7.40
(dd, J = 7.2, 1.5 Hz, 2H); 13C NMR (75 MHz, CDCl3) d 14.0, 62.7,
69.2, 122.8, 125.7, 126.3, 127.7, 128.9, 134.1, 140.6, 144.7, 172.6;
FT-IR (KBr pellet, cmꢀ1) 3454, 2980, 2932, 1727, 1460, 1382,
1213, 1196, 1083, 1022, 751, 685; HRMS (ESI-TOF) calcd for C14-
[M+Na]+: 461.1760, found: 461.1772; [
a
]
D
25 = ꢀ35.6 (c 1.1, CHCl3),
99% ee; HPLC (column, CHIRALCEL OD-H, Hexane/2-Propa-
nol = 96:4, flow rate 1.0 mL/min, 20 °C, detection UV 210 nm) tR
of minor isomer 17.2 min, tR of major isomer 20.6 min. The abso-
lute configuration was tentatively assigned by analogy of the spe-
cific rotation.
H14NaO3S [M+Na]+: 285.0561, found: 285.0573; [
a
]
D
25 = ꢀ13.6 (c
4.5.5. (R)-Ethyl 2-(3,5-diphenylfuran-2-yl)-2-hydroxyacetate 6e
1H NMR (300 MHz, CDCl3) d 1.25 (t, J = 7.2 Hz, 3H), 3.60 (d,
J = 6.0 Hz, 1H), 4.25–4.33 (m, 2H), 5.35 (d, J = 6.0 Hz, 1H), 6.83 (s,
1H), 7.28–7.49 (m, 6H), 7.58 (d, J = 2.4 Hz, 2H), 7.59 (d, J = 2.4 Hz,
2H); 13C NMR (75 MHz, CDCl3) d 14.0, 62.6, 65.5, 106.8, 124.0,
127.6, 127.89, 127.94, 128.2, 128.7, 128.8, 130.1, 132.5, 145.5,
153.5, 171.6; FT-IR (KBr pellet, cmꢀ1) 3481, 3059, 2980, 1739,
1486, 1451, 1264, 1222, 1071, 758, 696; HRMS (ESI-TOF) calcd
1.00, CHCl3), 99% ee; HPLC (column, CHIRALCEL OD-H, Hexane/2-
Propanol = 96:4, flow rate 1.0 mL/min, 20 °C, detection UV
210 nm) tR of minor isomer 18.1 min, tR of major isomer
22.0 min. The absolute configuration was tentatively assigned by
analogy of the specific rotation.
4.5.10. (R)-Ethyl 2-(5-(((tert-butyldiphenylsilyl)oxy)- methyl)-
thiophen-2-yl)-2-hydroxyacetate 6j
for C20H18KO4 [M+K]+: 361.0842, found: 361.0830; [
a]
25 = ꢀ19.5
1H NMR (300 MHz, CDCl3) d 1.08 (s, 9H), 1.31 (t, J = 7.2 Hz, 3H),
3.46 (d, J = 6.6 Hz, 1H), 4.26–4.34 (m, 2H), 4.83 (s, 2H), 5.36 (d,
J = 6.3 Hz, 1H), 6.70 (d, J = 3.6 Hz, 1H), 6.92 (d, J = 3.6 Hz, 1H),
7.37–7.44 (m, 6H), 7.69 (d, J = 7.8 Hz, 4H); 13C NMR (75 MHz,
CDCl3) d 14.0, 19.2, 26.7, 61.6, 62.5, 69.2, 123.3, 124.9, 127.7,
D
(c 1.05, CHCl3), 82% ee; HPLC (column, CHIRALCEL OD-H, Hexane/
2-Propanol = 96:4, flow rate 1.0 mL/min, 20 °C, detection UV
210 nm) tR of major isomer 25.8 min, tR of minor isomer
37.6 min. The absolute configuration was tentatively assigned by
analogy of the specific rotation.
129.7, 133.1, 135.6, 140.3, 145.4, 172.5; FT-IR (KBr pellet, cmꢀ1
)
3487, 3068, 2934, 2856, 1739, 1428, 1268, 1211, 1107, 1076,
4.5.6. (R)-Ethyl 2-(4,5-diphenylfuran-2-yl)-2-hydroxyacetate 6f
1H NMR (300 MHz, CDCl3) d 1.32 (t, J = 7.2 Hz, 3H), 3.40 (br s,
1H), 4.27–4.40 (m, 2H), 5.25 (s, 1H), 6.53 (s, 1H), 7.30–7.52 (m,
10H); 13C NMR (75 MHz, CDCl3) d 14.1, 62.7, 67.0, 112.8, 123.0,
126.3, 127.3, 127.8, 128.4, 128.63, 128.64, 130.7, 133.9, 148.9,
149.8, 171.4; FT-IR (KBr pellet, cmꢀ1) 3390, 2920, 2853, 1743,
1671, 1446, 1252, 1188, 764, 697; HRMS (ESI-TOF) calcd for C20-
826, 705; HRMS (ESI-TOF) calcd for C25H30NaO4SSi [M+Na]+:
477.1532, found: 477.1544; [
a]
D
25 = ꢀ24.5 (c 1.12, CHCl3), 99% ee;
HPLC (column, CHIRALCEL OD-H, Hexane/2-Propanol = 96:4, flow
rate 1.0 mL/min, 20 °C, detection UV 210 nm) tR of minor isomer
19.5 min, tR of major isomer 43.2 min. The absolute configuration
was tentatively assigned by analogy of the specific rotation.
H18NaO4 [M+Na]+: 345.1103, found: 345.1116; [
a
]
D
25 = ꢀ36.1 (c
4.5.11. (R)-tert-Butyl 2-(2-ethoxy-1-hydroxy-2-oxoethyl)-1H-
pyrrole-1-carboxylate 6k9
0.88, CHCl3), 99% ee; HPLC (column, CHIRALCEL OD-H, Hexane/2-
Propanol = 96:4, flow rate 1.0 mL/min, 20 °C, detection UV
210 nm) tR of minor isomer 18.2 min, tR of major isomer
26.2 min. The absolute configuration was tentatively assigned by
analogy of the specific rotation.
1H NMR (300 MHz, CDCl3) d 1.24 (t, J = 7.2 Hz, 3H), 1.57 (s, 9H),
4.04 (d, J = 8.1 Hz, 1H), 4.18–4.26 (m, 2H), 5.37 (d, J = 7.5 Hz, 1H),
6.12 (dd, J = 3.6, 3.3 Hz, 1H), 6.25 (dd, J = 3.3, 1.5 Hz, 1H), 7.38
(dd, J = 3.6, 1.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) d 14.2, 27.9,
61.6, 67.8, 84.8, 110.4, 115.5, 122.5, 131.7, 149.8, 171.6; FT-IR
(neat, cmꢀ1) 3491, 3154, 2982, 2938, 1739, 1478, 1423, 1395,
1350, 1240, 1145, 1053, 950, 847; HRMS (ESI-TOF) calcd for C13-
4.5.7. (R)-Ethyl 2-hydroxy-2-(thiophen-2-yl)acetate 6g9
1H NMR (300 MHz, CDCl3) d 1.29 (t, J = 7.2 Hz, 3H), 3.54 (d,
J = 6.3 Hz, 1H), 4.21–4.36 (m, 2H), 5.40 (d, J = 6.3 Hz, 1H), 6.99
(dd, J = 5.1, 3.6 Hz 1H), 7.10 (d, J = 3.6 Hz, 1H), 7.28 (dd, J = 5.1,
1.2 Hz 1H); 13C NMR (75 MHz, CDCl3) d 14.0, 62.6, 69.1, 125.3,
125.6, 126.9, 141.5, 172.6; FT-IR (neat, cmꢀ1) 3453, 3012, 2961,
2912, 1751, 1685, 1512, 1399, 1328, 1249, 1188, 1090, 1032,
918, 873; HRMS (APCI-TOF) calcd for C8H10NaO3S [M+Na]+:
H19NNaO5 [M+Na]+: 292.1161, found: 292.1160; [
a]
25 = ꢀ50.7 (c
D
0.96, CHCl3), 99% ee; HPLC (column, CHIRALPAK AD-H, Hexane/2-
Propanol = 97:3, flow rate 1.0 mL/min, 20 °C, detection UV
254 nm) tR of minor isomer 18.0 min, tR of major isomer
22.6 min. The absolute configuration was tentatively assigned by
analogy of the specific rotation.
209.0248, found: 209.0250; [
a
]
25 = ꢀ73.8 (c 0.55, CHCl3), 98% ee;
D
HPLC (column, CHIRALPAK AD-H, Hexane/2-Propanol = 96:4, flow
rate 1.0 mL/min, 20 °C, detection UV 210 nm) tR of minor isomer
15.8 min, tR of major isomer 17.7 min. The absolute configuration
was tentatively assigned by analogy of the specific rotation.
4.5.12. (R)-tert-Butyl 2-(2-ethoxy-1-hydroxy-2-oxoethyl)-5-
methyl-1H-pyrrole-1-carboxylate 6l
1H NMR (300 MHz, CDCl3) d 1.26 (t, J = 7.2 Hz, 3H), 1.58 (s, 9H),
4.05 (d, J = 9.3 Hz, 1H), 4.18–4.25 (m, 2H), 5.27 (d, J = 9.3 Hz, 1H),
5.87 (d, J = 3.3 Hz, 1H), 6.12 (dd, J = 3.3 Hz, 1H); 13C NMR
(75 MHz, CDCl3) d 14.2, 16.7, 28.0, 61.6, 68.6, 85.0, 110.1, 114.3,
131.8, 132.9, 151.0, 171.9; FT-IR (neat, cmꢀ1) 3504, 2978, 2931,
1739, 1392, 1347, 1259, 1129, 1071, 850, 788; HRMS (ESI-TOF)
4.5.8. (R)-Ethyl 2-hydroxy-2-(5-methylthiophen-2-yl)acetate 6h
1H NMR (300 MHz, CDCl3) d 1.29 (t, J = 7.2 Hz, 3H), 2.45 (s, 3H),
3.42 (d, J = 6.6 Hz, 1H), 4.21–4.35 (m, 2H), 5.30 (d, J = 6.6 Hz, 1H),
6.62 (d, J = 3.6 Hz, 1H), 6.87 (d, J = 3.6 Hz, 1H); 13C NMR (75 MHz,
CDCl3) d 14.0, 15.3, 62.4, 69.1, 124.9, 125.4, 138.8, 140.5, 172.6;
FT-IR (neat, cmꢀ1) 3480, 2982, 2923, 1735, 1448, 1367, 1267,
1213, 1072, 1022, 799; HRMS (ESI-TOF) calcd for C9H12NaO3S
calcd for
C
14H21NNaO5 [M+Na]+: 306.1317, found: 306.1317;
[a]
25 = ꢀ40.3 (c 0.86, CHCl3), 98% ee; HPLC (column, CHIRALPAK
D
AD-H, Hexane/2-Propanol = 97:3, flow rate 1.0 mL/min, 20 °C,
detection UV 210 nm) tR of minor isomer 13.5 min, tR of major